Literature DB >> 9876863

Validity of a cognitive computerized assessment system in brain-injured patients.

M S Keith1, S W Stanislav, K A Wesnes.   

Abstract

The primary objective of the study was to investigate the criterion validity of the Cognitive Drug Research (CDR) computerized system in assessing cognitive functioning among persons with brain injury or other organic illness. Understanding the cognitive effects of pharmacotherapy is important in improving long-term rehabilitation outcomes in persons with organic disorders. The CDR system evaluates cognitive skills of attention, short-term or working memory, long-term memory, and visuomotor and motor functioning. For validity testing, correlation coefficients were obtained from an analysis of CDR scores to IQ and Folstein Mini-Mental State Exam (MMSE) scores. Subtests of the CDR system that correlated with the MMSE were choice reaction time (R = -0.542, p = 0.04), spatial working memory (R = 0.938, p = 0.01), and word recognition (R = -0.949, p = 0.01). These tests primarily measured attention and working memory. Correlations between the CDR and IQ scores were not evident. In summary, the data suggest the CDR assessment system has high patient acceptability by persons with traumatic brain injury, and is a useful tool in assessing certain domains of cognition, specifically short-term memory, discrimination, and identification skills.

Entities:  

Mesh:

Year:  1998        PMID: 9876863     DOI: 10.1080/026990598121945

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  14 in total

1.  Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study.

Authors:  Charles A Czeisler; James K Walsh; Keith A Wesnes; Sanjay Arora; Thomas Roth
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

2.  SCIRehab Project series: the psychology taxonomy.

Authors:  Catherine Wilson; Toby Huston; Jill Koval; Samuel A Gordon; Andrea Schwebel; Julie Gassaway
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

3.  Assessment of cognition in early dementia.

Authors:  Nina B Silverberg; Laurie M Ryan; Maria C Carrillo; Reisa Sperling; Ronald C Petersen; Holly B Posner; Peter J Snyder; Robin Hilsabeck; Michela Gallagher; Jacob Raber; Albert Rizzo; Katherine Possin; Jonathan King; Jeffrey Kaye; Brian R Ott; Marilyn S Albert; Molly V Wagster; John A Schinka; C Munro Cullum; Sarah T Farias; David Balota; Stephen Rao; David Loewenstein; Andrew E Budson; Jason Brandt; Jennifer J Manly; Lisa Barnes; Adriana Strutt; Tamar H Gollan; Mary Ganguli; Debra Babcock; Irene Litvan; Joel H Kramer; Tanis J Ferman
Journal:  Alzheimers Dement       Date:  2011-05-01       Impact factor: 21.566

4.  The effect of modafinil on cognitive function in breast cancer survivors.

Authors:  Sadhna Kohli; Susan G Fisher; Yolande Tra; M Jacob Adams; Mark E Mapstone; Keith A Wesnes; Joseph A Roscoe; Gary R Morrow
Journal:  Cancer       Date:  2009-06-15       Impact factor: 6.860

Review 5.  A systematic review of cognitive function in patients with glioblastoma undergoing surgery.

Authors:  Rohitashwa Sinha; Jade Marie Stephenson; Stephen John Price
Journal:  Neurooncol Pract       Date:  2019-04-23

6.  The value of assessing cognitive function in drug development.

Authors:  K A Wesnes
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

7.  Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.

Authors:  Chris Edgar; Peter J Jongen; Evert Sanders; Christian Sindic; Sophie Goffette; Michel Dupuis; Philippe Jacquerye; Daniel Guillaume; Regine Reznik; Keith Wesnes
Journal:  BMC Neurol       Date:  2011-06-07       Impact factor: 2.474

8.  Armodafinil improves wakefulness and long-term episodic memory in nCPAP-adherent patients with excessive sleepiness associated with obstructive sleep apnea.

Authors:  Thomas Roth; Gregory A Rippon; Sanjay Arora
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

9.  Randomized, double-blind, placebo-controlled, crossover study of the effects of lisdexamfetamine dimesylate and mixed amphetamine salts on cognition throughout the day in adults with attention-deficit/hyperactivity disorder.

Authors:  Patrick T Martin; Mary Corcoran; Pinggao Zhang; Alain Katic
Journal:  Clin Drug Investig       Date:  2014-02       Impact factor: 2.859

10.  Rationale, design and methods for a community-based study of clustering and cumulative effects of chronic disease processes and their effects on ageing: the Busselton healthy ageing study.

Authors:  Alan James; Michael Hunter; Leon Straker; John Beilby; Romola Bucks; Tim Davis; Robert H Eikelboom; David Hillman; Jennie Hui; Joe Hung; Matthew Knuiman; David A Mackey; Robert U Newton; Lyle J Palmer; Aw Bill Musk
Journal:  BMC Public Health       Date:  2013-10-08       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.